Dr. Kumar Srinivasan
Kumar Srinivasan, Ph.D., MBA, in his most recent role served as executive vice president and chief business officer at Turning Point Therapeutics with responsibility for corporate strategy and business development,
Dr. Shubhada Chiplunkar
Prof Shubhada Chiplunkar Former Director of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai and the Head of Cancer Immunology and Immunotherapy
Hariharnath Buggana
Hariharnath Buggana is the Managing Director of InvAscent India – a private equity firm focused on Indian healthcare, pharma, and medtech industries. Prior to this, Hari was a consultant with
Dr. Bruce Carter
Dr. Bruce LA Carter is an independent member of the board at Dr. Reddy’s for the past seven years. He started his long and illustrious career in the biopharma industry
Patrick Aghanian
Patrick Aghanian is the Chief Executive Officer for European Generics at Dr. Reddy’s Laboratories Limited and a member of Dr. Reddy’s Management Council. Patrick joined Dr. Reddy’s from Zentiva in
Parag Agarwal
Parag Agarwal is the Chief Financial Officer of Dr. Reddy’s Laboratories Limited. He joined Dr. Reddy’s from London-based Reckitt Benckiser PLC, where he was the CFO for Health. In a
Satish Reddy
Satish Reddy is the Chairman of Dr. Reddy’s Laboratories. He joined the company in 1993 and since then, has held positions of increasing responsibility. Satish led the organization’s transition from
Murali Ramachandra, PhD
Prior to assuming the CEO responsibility, Murali was serving as Chief Scientific Officer at Aurigene. Murali has extensive experience of over 25 years in running successful and innovative research and
Susanta Samajdar, PhD
Susanta received his PhD in Synthetic Organic Chemistry from Indian Association for the Cultivation of Science (IACS), Kolkata and subsequently moved to MD Anderson Cancer Centre for a Post-Doctoral training